New study tracks rare muscle disease to pave way for future treatments

NCT ID NCT05653544

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 150 people with primary mitochondrial myopathy, a rare genetic muscle disease, to understand how the condition changes over time. Researchers will measure muscle function, biomarkers, and imaging to find signs of disease progression. The goal is to identify useful measures for future clinical trials, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify key markers of disease progression, helping design better clinical trials for future treatments.

What could go wrong

This is an observational study, not a treatment trial. It will not directly improve symptoms, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY MITOCHONDRIAL MYOPATHIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Universitario 12 Octubre

    RECRUITING

    Madrid, Madrid, 28041, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••